These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22203530)

  • 1. A piece of my mind. Making the call.
    Welch HG
    JAMA; 2011 Dec; 306(24):2649-50. PubMed ID: 22203530
    [No Abstract]   [Full Text] [Related]  

  • 2. Missing the mark on prostate-specific antigen screening.
    Miller DC; Hollenbeck BK
    JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542
    [No Abstract]   [Full Text] [Related]  

  • 3. Grading the new US Preventive Services Task Force prostate cancer screening recommendation.
    Volk RJ; Wolf AM
    JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer screening--the evidence, the recommendations, and the clinical implications.
    Chou R; LeFevre ML
    JAMA; 2011 Dec; 306(24):2721-2. PubMed ID: 22203543
    [No Abstract]   [Full Text] [Related]  

  • 5. USPSTF finds little evidence to support advising PSA screening in any man.
    Slomski A
    JAMA; 2011 Dec; 306(23):2549-51. PubMed ID: 22187266
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer screening--time to abandon one-size-fits-all approach?
    Kim J; Davis JW
    JAMA; 2011 Dec; 306(24):2717-8. PubMed ID: 22203541
    [No Abstract]   [Full Text] [Related]  

  • 7. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
    Schröder FH
    N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
    Brett AS; Ablin RJ
    N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 10. One man at a time--resolving the PSA controversy.
    McNaughton-Collins MF; Barry MJ
    N Engl J Med; 2011 Nov; 365(21):1951-3. PubMed ID: 22029758
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply from Authors re: Goutham Vemana, Gerald L. Andriole. Bad Habits May Be Hard to Break. Eur Urol 2013;63:426-7: Changing Habits.
    Nordström T; Clements MS; Adolfsson J; Grönberg H
    Eur Urol; 2013 Mar; 63(3):427. PubMed ID: 23265389
    [No Abstract]   [Full Text] [Related]  

  • 12. PSA screening: the USPSTF got it right.
    Lefevre M
    J Fam Pract; 2013 Nov; 62(11):617, 619. PubMed ID: 24288702
    [No Abstract]   [Full Text] [Related]  

  • 13. PSA test not recommended by Canadian Task Force.
    Tanday S
    Lancet Oncol; 2014 Dec; 15(13):e589. PubMed ID: 25499287
    [No Abstract]   [Full Text] [Related]  

  • 14. Informed consent for prostate cancer screening--a call for equity in medical interventions.
    Thompson IM
    Urology; 2003 Jan; 61(1):15-6. PubMed ID: 12559257
    [No Abstract]   [Full Text] [Related]  

  • 15. Making an informed choice about PSA screening.
    Ward J; Gattellari M
    Aust Fam Physician; 2001 Jul; 30(7):715-6. PubMed ID: 11558209
    [No Abstract]   [Full Text] [Related]  

  • 16. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

  • 17. What would you do, doctor?
    Smith JA
    J Urol; 2009 Aug; 182(2):421-2. PubMed ID: 19524982
    [No Abstract]   [Full Text] [Related]  

  • 18. New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough.
    Wroclawski ML
    Einstein (Sao Paulo); 2017; 15(3):7-10. PubMed ID: 29091165
    [No Abstract]   [Full Text] [Related]  

  • 19. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing.
    Messing EM; Albertsen P; Andriole GL; Carroll PR; Klein EA
    Urol Oncol; 2012; 30(1):117-9. PubMed ID: 22243597
    [No Abstract]   [Full Text] [Related]  

  • 20. Revisiting my personal decision about prostate-specific antigen testing in 2005.
    Barry MJ
    BJU Int; 2005 Nov; 96(7):954-6. PubMed ID: 16225507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.